Bristol-Myers Squibb Boosts FY21 Outlook As Q3 Results Top Estimates - Quick Facts

While reporting financial results for the third quarter on Wednesday, biopharmaceutical company Bristol-Myers Squibb Co. (BMY) raised its adjusted earnings guidance for the full-year 2021.

from RTT - Earnings https://ift.tt/3jIO9WW
via IFTTT